Data Point: Savings Available Under Full Generic Substitution of Multiple Source Brand Drugs in Medicare Part D


ASPE analyzed Part D prescription drug event data from 2016 to estimate spending on brand drugs with generic therapeutic equivalents.


"DP-Multisource-Brands-in-Part-D.pdf" (pdf, 248.35Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®